U.S. markets closed
  • S&P Futures

    3,847.50
    +5.00 (+0.13%)
     
  • Dow Futures

    30,851.00
    +9.00 (+0.03%)
     
  • Nasdaq Futures

    13,561.25
    +75.75 (+0.56%)
     
  • Russell 2000 Futures

    2,144.80
    -1.00 (-0.05%)
     
  • Crude Oil

    52.75
    +0.14 (+0.27%)
     
  • Gold

    1,847.30
    -3.60 (-0.19%)
     
  • Silver

    25.48
    -0.06 (-0.25%)
     
  • EUR/USD

    1.2168
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    1.0400
    0.0000 (0.00%)
     
  • Vix

    23.02
    -0.17 (-0.73%)
     
  • GBP/USD

    1.3738
    +0.0006 (+0.05%)
     
  • USD/JPY

    103.6760
    +0.0490 (+0.05%)
     
  • BTC-USD

    32,282.91
    -232.03 (-0.71%)
     
  • CMC Crypto 200

    650.43
    +3.10 (+0.48%)
     
  • FTSE 100

    6,654.01
    +15.16 (+0.23%)
     
  • Nikkei 225

    28,682.79
    +136.61 (+0.48%)
     

ACM Research (ACMR) Soars: Stock Adds 9.4% in Session

Zacks Equity Research
·2 min read

ACM Research, Inc. ACMR) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company — as the stock is now down 36.7% in the past one-month time frame.

The company has seen two negative estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

ACM Research currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

 

ACM Research, Inc. Price

ACM Research, Inc. Price
ACM Research, Inc. Price

ACM Research, Inc. price | ACM Research, Inc. Quote

 

A better-ranked stock in the Computer and Technology sector is Atomera Incorporated ATOM, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ACM Research, Inc. (ACMR) : Free Stock Analysis Report
 
Atomera Incorporated (ATOM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research